ReviewThe Journal of clinical endocrinology and metabolism2020

GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists.

Jens Juul Holst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.